NASDAQ:NARI

Inari Medical (NARI) Stock Forecast, Price & News

$63.55

-1.92 (-2.93%)

(As of 09/22/2023 ET)

Compare

Today's Range: $63.28
▼
$65.62
50-Day Range: $55.60
▼
$71.67
52-Week Range: $52.59
▼
$83.84

Volume: 399,773 shs
Average Volume: 498,479 shs
Market Capitalization: $3.64 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $85.22

Inari Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.86 Rating Score
Upside/Downside: 34.1% Upside
$85.22 Price Target
Short Interest: Bearish
9.21% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.26
Based on 3 Articles This Week
Insider Trading: Selling Shares
$8.43 M Sold Last Quarter
Proj. Earnings Growth: 725.00%
From $0.04 to $0.33 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

289th out of 971 stocks

Medical Devices Industry

6th out of 16 stocks

3.4

Analyst's Opinion

Consensus Rating
Inari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $85.22, Inari Medical has a forecasted upside of 34.1% from its current price of $63.55.
Amount of Analyst Coverage
Inari Medical has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
9.21% of the float of Inari Medical has been sold short.
Short Interest Ratio / Days to Cover
Inari Medical has a short interest ratio ("days to cover") of 5.8.
Change versus previous month
Short interest in Inari Medical has recently increased by 2.28%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Inari Medical does not currently pay a dividend.
Dividend Growth
Inari Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NARI.

2.4

News and Social Media Coverage

News Sentiment
Inari Medical has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Inari Medical this week, compared to 3 articles on an average week.
Search Interest
7 people have searched for NARI on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
MarketBeat Follows
3 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,432,648.00 in company stock.
Percentage Held by Insiders
11.90% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
87.75% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Inari Medical are expected to grow by 725.00% in the coming year, from $0.04 to $0.33 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Inari Medical is -211.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inari Medical is -211.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Inari Medical has a P/B Ratio of 8.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Inari Medical (NASDAQ:NARI) Stock

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NARI Price History

30 days | 90 days | 365 days | Advanced Chart

NARI Stock News Headlines

September 21, 2023 | americanbankingnews.com

William Hoffman Sells 25,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) Stock

September 14, 2023 | finance.yahoo.com

CFO Mitch Hill Sells 6,500 Shares of Inari Medical Inc

September 24, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

September 14, 2023 | americanbankingnews.com

Inari Medical, Inc. (NASDAQ:NARI) Given Consensus Rating of "Moderate Buy" by Analysts

August 11, 2023 | finance.yahoo.com

Wall Street Analysts See a 36.39% Upside in Inari Medical, Inc. (NARI): Can the Stock Really Move This High?

August 7, 2023 | markets.businessinsider.com

Inari Medical (NARI) Receives a Hold from Truist Financial

August 6, 2023 | finance.yahoo.com

Is Inari Medical, Inc. (NASDAQ:NARI) Expensive For A Reason? A Look At Its Intrinsic Value

August 4, 2023 | msn.com

Morgan Stanley Reiterates Inari Medical (NARI) Overweight Recommendation

September 24, 2023 | Altimetry (Ad)

DOD Consultant's big 2024 prediction looks to be coming true

Earlier this year, a Department of Defense (DOD) consultant went public with a big prediction…About how a surprising 2024 event would dramatically affect you and your money. The most recent figures (published June 9th 2023) indicate he’s very likely to be right. Get the facts—learn how to prepare. Full analysis available free of charge here…

August 4, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), Inari Medical (NARI) and Sarepta Therapeutics (SRPT)

August 3, 2023 | msn.com

Inari Medical Stock Gained 21% on Thursday - Here's Why It Soared

August 3, 2023 | finance.yahoo.com

Why Shares of Inari Medical Are Up Thursday

August 3, 2023 | msn.com

Inari Medical GAAP EPS of $0.04 beats by $0.16, revenue of $119M beats by $2.28M

August 3, 2023 | finance.yahoo.com

Inari Medical Reports Second Quarter 2023 Financial Results

August 3, 2023 | finance.yahoo.com

Inari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue Estimates

August 1, 2023 | markets.businessinsider.com

Inari Medical earnings: here's what Wall Street expects

July 31, 2023 | msn.com

Inari Medical: Approaching Interesting Levels

July 26, 2023 | finance.yahoo.com

Inari Medical to Present at the 43rd Annual Canaccord Growth Conference

July 20, 2023 | finance.yahoo.com

Should You Think About Buying Inari Medical, Inc. (NASDAQ:NARI) Now?

July 13, 2023 | finance.yahoo.com

Inari Medical to Announce Second Quarter 2023 Financial Results

July 6, 2023 | finance.yahoo.com

QooQoo Healthcare Marketing Agency Earns Multiple Marketing Awards

July 4, 2023 | msn.com

Reasons to Add Inari Medical (NARI) Stock to Your Portfolio

June 22, 2023 | benzinga.com

Catheter Introducer Sheaths Market Size to Surpass US$ 2.06 Billion by 2031 - Growth Plus Reports

June 15, 2023 | seekingalpha.com

NARI Inari Medical, Inc.

June 12, 2023 | finance.yahoo.com

Inari Medical (NASDAQ:NARI) shareholders have earned a 7.4% CAGR over the last three years

June 7, 2023 | finance.yahoo.com

Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism

May 25, 2023 | finance.yahoo.com

Inari Medical Announces the Release of 2022 Ethos and Sustainability Report

See More Headlines

Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Company Calendar

Last Earnings: 8/02/2023
Today: 9/23/2023
Next Earnings (Estimated): 11/01/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NARI
CUSIP: N/A
CIK: 1531048
Web: www.inarimedical.com
Phone: 877-923-4747
Fax: N/A
Employees: 1,100
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $85.22
High Stock Price Forecast: $100.00
Low Stock Price Forecast: $65.00
Forecasted Upside/Downside: +34.1%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.86
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.30)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 1,588.75
P/E Growth: N/A
Net Income: $-29,270,000.00
Net Margins: -3.66%
Pretax Margin: -2.80%
Return on Equity: -3.80%
Return on Assets: -3.18%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.63
Quick Ratio: 6.97

Sales & Book Value

Annual Sales: $383.47 million
Price / Sales: 9.50
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.77 per share
Price / Book: 8.18

Miscellaneous

Outstanding Shares: 57,350,000
Free Float: 50,527,000
Market Cap: $3.64 billion
Optionable: Not Optionable
Beta: 1.00

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Andrew J. Hykes (Age 49)
CEO, Pres & Director
Comp: $863.78k

Mr. Mitchell C. Hill (Age 64)
Chief Financial Officer
Comp: $811.08k

Dr. Thomas M. Tu M.D. (Age 50)
Chief Medical Officer
Comp: $812.94k

Mr. Paul A. Koehn (Age 60)
Sr. VP of Operations

Ms. Angela Ahmad
Gen. Counsel & Sec.

Mr. Eric Khairy
Sr. VP of Marketing

Mr. John R. Borrell (Age 56)
Sr. VP of Sales

Ms. Tara Dunn
Sr. VP of Clinical Affairs & Market Devel.

Mr. Brian Strauss
Sr. VP of Engineering

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NARI Stock - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NARI shares.
View NARI analyst ratings or view top-rated stocks.
What is Inari Medical's stock price forecast for 2023?: 7 brokerages have issued 1-year price objectives for Inari Medical's shares. Their NARI share price forecasts range from $65.00 to $100.00. On average, they expect the company's stock price to reach $85.22 in the next twelve months. This suggests a possible upside of 34.1% from the stock's current price.
View analysts price targets for NARI or view top-rated stocks among Wall Street analysts.
How have NARI shares performed in 2023?: Inari Medical's stock was trading at $63.56 at the start of the year. Since then, NARI stock has decreased by 0.0% and is now trading at $63.55.
View the best growth stocks for 2023 here.
When is Inari Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our NARI earnings forecast.
How were Inari Medical's earnings last quarter?: Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.04 EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.18. The company had revenue of $119.01 million for the quarter, compared to the consensus estimate of $116.67 million. Inari Medical had a negative net margin of 3.66% and a negative trailing twelve-month return on equity of 3.80%. Inari Medical's revenue for the quarter was up 28.3% on a year-over-year basis. During the same period last year, the firm posted ($0.19) EPS.
What ETFs hold Inari Medical's stock?: ETFs with the largest weight of Inari Medical (NASDAQ:NARI) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Principal Healthcare Innovators ETF (BTEC) and IQ Healthy Hearts ETF (HART).iShares U.S. Medical Devices ETF (IHI).
What guidance has Inari Medical issued on next quarter's earnings?: Inari Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $482.00 million-$492.00 million, compared to the consensus revenue estimate of $483.82 million.
What other stocks do shareholders of Inari Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?: (NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.
What is Inari Medical's stock symbol?: Inari Medical trades on the NASDAQ under the ticker symbol "NARI."
Who are Inari Medical's major shareholders?: Inari Medical's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (11.13%), Franklin Resources Inc. (4.74%), Alliancebernstein L.P. (4.02%), State Street Corp (3.09%), Brown Advisory Inc. (2.45%) and Credit Suisse AG (2.07%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Presidio Management Group X Ll, Stanley Tang, Thomas Tu and William Hoffman.
View institutional ownership trends.
How do I buy shares of Inari Medical?: Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Inari Medical's stock price today?: One share of NARI stock can currently be purchased for approximately $63.55.
How much money does Inari Medical make?: Inari Medical (NASDAQ:NARI) has a market capitalization of $3.64 billion and generates $383.47 million in revenue each year. The company earns $-29,270,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis.
How many employees does Inari Medical have?: The company employs 1,100 workers across the globe.
How can I contact Inari Medical?: Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com.

This page (NASDAQ:NARI) was last updated on 9/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Inari Medical (NARI) Stock Forecast, Price & News

Inari Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Inari Medical (NASDAQ:NARI) Stock

NARI Price History

NARI Stock News Headlines

NARI Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

NARI Stock - Frequently Asked Questions

Overall MarketRank^™